Page last updated: 2024-11-02

pd 98059 and Behavior Disorders

pd 98059 has been researched along with Behavior Disorders in 1 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Research Excerpts

ExcerptRelevanceReference
"In search for drugs to treat neuropsychiatric disorders wherein neurotrophic and neurogenic properties are affected, two neurotrophically active small molecules specially crafted following natural product leads based on 2-oxa-spiro[5."1.42A novel natural product inspired scaffold with robust neurotrophic, neurogenic and neuroprotective action. ( Chakravarty, S; Das, T; Jhelum, P; Kernie, SG; Kootar, S; Kumar, A; Maitra, S; Mehta, G; Pabbaraja, S; Rajan, WD; Reddy, RG; Samanta, A; Samineni, R, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chakravarty, S1
Maitra, S1
Reddy, RG1
Das, T1
Jhelum, P1
Kootar, S1
Rajan, WD1
Samanta, A1
Samineni, R1
Pabbaraja, S1
Kernie, SG1
Mehta, G1
Kumar, A1

Other Studies

1 other study available for pd 98059 and Behavior Disorders

ArticleYear
A novel natural product inspired scaffold with robust neurotrophic, neurogenic and neuroprotective action.
    Scientific reports, 2015, Sep-21, Volume: 5

    Topics: Animals; Azepines; Benzamides; Brain-Derived Neurotrophic Factor; Cell Line; Disease Models, Animal;

2015